ArticleBMC cardiovascular disorders2026
Risk factors and outcomes of HPH in high-altitude residents via echocardiographic evaluation.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOver 80 million people live above 2,500 m, where hypobaric hypoxia increases hypoxic pulmonary hypertension (HPH) risk. In Qinghai, China (> 3,000 m), over 5 million face a high HPH burden with limited medical resources.
objectiveTo evaluate risk factors and outcomes of HPH in high-altitude residents using echocardiography.
methodsThis retrospective study analyzed 627 HPH patients (PASP > 50 mmHg) in Qinghai (2018-2022), categorized as moderate (50 < PASP < 70 mmHg) or severe (PASP ≥ 70 mmHg). Clinical, biochemical, and echocardiographic data were assessed, with mortality tracked via telephone follow-up after ≥ 1 year. Logistic and Cox regression identified severity and mortality predictors.
resultsAmong 627 high-altitude residents with HPH, 360 (57.4%) had moderate HPH (50 < PASP < 70 mmHg) and 267 (42.6%) had severe HPH (PASP ≥ 70 mmHg). Severe HPH was associated with higher APTT (p = 0.004), LPa (p = 0.004), cyanosis (p = 0.003), and right ventricular hypertrophy (p = 0.001) via multivariate logistic regression. Mortality predictors, identified by multivariate Cox regression, included LPa (p = 0.001), atrial fibrillation (p = 0.003), heart failure (p = 0.021), and alcohol consumption (p = 0.013).
conclusionIn Qinghai's high-altitude residents, APTT, LPa, cyanosis, and right ventricular hypertrophy drive severe HPH, while LPa, atrial fibrillation, heart failure, and alcohol consumption predict mortality. Monitoring APTT and LPa may aid early detection, and managing modifiable factors like alcohol and atrial fibrillation could reduce mortality in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.